Streetbeat News

TELO

Telomir Pharmaceuticals Inc

Industry

Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

Open

4.11

Mkt cap

125M

Volume

41K

High

4.23

P/E Ratio

-6.70

52-wk high

20.72

Low

4.11

Div yield

N/A

52-wk low

3.11

In Thursday's pre-market session, several healthcare stocks showed significant movement. Aptorum Gr, Nuvectis Pharma, and Bright Green were among the top gainers, with shares increasing by 47.1%, 23.65%, and 20.99% respectively. On the losing side, Spruce Biosciences saw a dramatic drop of 78% following its Q4 earnings report. Other notable decliners include Kintara Therapeutics and Nuvation Bio.

Portfolio Pulse from Benzinga Insights

March 14, 2024 | 1:06 pm

In Tuesday's pre-market session, several healthcare stocks showed significant movement. Regulus Therapeutics led the gainers with an 84.8% increase, while Renalytix faced the largest drop among the losers, declining by 27.2%. Notably, Bioventus and CytomX Therapeutics released their Q4 earnings, influencing their stock prices.

Portfolio Pulse from Benzinga Insights

March 12, 2024 | 1:06 pm

Telomir Pharmaceuticals presented pre-clinical data for its lead development product at a conference in Singapore, indicating progress in its research and development efforts.

Portfolio Pulse from Benzinga Newsdesk

March 07, 2024 | 1:31 pm

Herbalife Ltd. (NYSE:HLF) shares plummeted by approximately 36% due to disappointing quarterly earnings, missing market expectations. The article also highlights significant movements in other stocks during Thursday's mid-day session, including notable gainers like JX Luxventure Limited and losers such as Treasure Global Inc.

Portfolio Pulse from Avi Kapoor

February 15, 2024 | 6:20 pm

AppLovin Corporation's shares surged by approximately 22% in pre-market trading after reporting Q4 earnings and sales that exceeded analyst expectations. Other stocks also showed significant movement in pre-market trading, with notable gainers including China Natural Resources, Inc., and JFrog Ltd., and losers like Treasure Global Inc., and Cineverse Corp.

Portfolio Pulse from Avi Kapoor

February 15, 2024 | 12:57 pm

Trading of Telomir Pharma shares, symbol TELO, has resumed after a temporary halt.

Portfolio Pulse from Benzinga Newsdesk

February 09, 2024 | 4:06 pm

Shares of Telomir Pharma (TELO) were halted due to a circuit breaker triggered by a significant downside movement. This action is typically taken to prevent panic selling and provide a cooling-off period for investors.

Portfolio Pulse from Benzinga Newsdesk

February 09, 2024 | 4:02 pm

Trading of Telomir Pharma shares has resumed, indicating a return to normal market operations for the company's stock.

Portfolio Pulse from Benzinga Newsdesk

February 09, 2024 | 3:57 pm

Shares of Telomir Pharma were halted due to a circuit breaker triggered by a significant downside movement. This action is typically taken to prevent a stock from crashing by pausing trading, allowing for a cooling-off period.

Portfolio Pulse from Benzinga Newsdesk

February 09, 2024 | 3:49 pm

Telomir Pharma's IPO shares began trading at $7 per share, which was also the price at which the IPO was priced.

Portfolio Pulse from Benzinga Newsdesk

February 09, 2024 | 3:48 pm

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.